Recommendations repealed
8.5.2025 Summary of COHERE Finland's recommendation on Nirsevimab in the prevention of lower respiratory tract infection caused by respiratory syncytial virus (RSV).File opens in a new tab pdf 193kB Approved at the meeting of COHERE on 7 May 2024. This recommendation is no longer in force but has been replaced by a recommendation approved by COHERE on 8 May 2025. Link to the replacing recommendation.